Sign in →

Test Code CNES Peripheral Nervous System Comprehensive Neuropathy, Autoimmune Evaluation, Serum


Ordering Guidance


Multiple neurological phenotype-specific autoimmune/paraneoplastic evaluations are available. For more information as well as phenotype-specific testing options, refer to Autoimmune Neurology Test Ordering Guide.

 

For a list of antibodies performed with each evaluation, see Autoimmune Neurology Antibody Matrix.



Specimen Required


Patient Preparation: For optimal antibody detection, specimen collection is recommended to occur before starting immunosuppressant medication or intravenous immunoglobulin (IVIg) treatment.

Supplies: Sarstedt Aliquot Tube, 5 mL (T914)

Collection Container/Tube:

Preferred: Red top

Acceptable: Serum gel

Submission Container/Tube: Plastic vial

Specimen Volume: 3 mL Serum

Collection Instructions: Centrifuge and aliquot serum into a plastic vial.


Profile Information

Test ID Reporting Name Available Separately Always Performed
CNEI Comprehensive Neuropathy Interp, S No Yes
AMPHS Amphiphysin Ab, S No Yes
AGN1S Anti-Glial Nuclear Ab, Type 1 No Yes
ANN1S Anti-Neuronal Nuclear Ab, Type 1 No Yes
ANN3S Anti-Neuronal Nuclear Ab, Type 3 No Yes
APBIS AP3B2 IFA, S No Yes
CS1CS CASPR1-IgG CBA, S No Yes
CS2CS CASPR2-IgG CBA, S No Yes
CONCS Contactin-1 IgG CBA, S No Yes
CRMS CRMP-5-IgG, S No Yes
GQ1ES GQ1b-IgG ELISA, S Yes Yes
IGG_D IgG Disialo. GD1b No Yes
IGG_M IgG Monos. GM1 No Yes
IG5CS IgLON5 CBA, S No Yes
IGM_D IgM Disialo. GD1b No Yes
IGM_M IgM Monos. GM1 No Yes
LG1CS LGI1-IgG CBA, S No Yes
MAGES MAG IgM, S Yes Yes
NF4FS Neurofascin-155 IgG4, S No Yes
PCAB2 Purkinje Cell Cytoplasmic Ab Type 2 No Yes

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
AGNBS AGNA-1 Immunoblot, S No No
AGNTS AGNA-1 Titer, S No No
APHTS Amphiphysin Ab Titer, S No No
AMIBS Amphiphysin Immunoblot, S No No
AN1BS ANNA-1 Immunoblot, S No No
AN1TS ANNA-1 Titer, S No No
AN2BS ANNA-2 Immunoblot, S No No
AN3TS ANNA-3 Titer, S No No
APBCS AP3B2 CBA, S No No
APBTS AP3B2 IFA Titer, S No No
CRMTS CRMP-5-IgG Titer, S No No
CRMWS CRMP-5-IgG Western Blot, S No No
IGDTS IgG Disialo GD1b Titer, S No No
IGMTS IgG Monos GM1 Titer, S No No
IG5TS IgLON5 IFA Titer, S No No
IMDTS IgM Disialo GD1b Titer, S No No
IMMTS IgM Monos GM1 Titer, S No No
MP1BS MAP1B Immunoblot, S No No
PC2TS PCA-2 Titer, S No No

Testing Algorithm

To assess the probability of your patient having chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) vs mimic disorders, see the Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) calculator.

 

If the indirect immunofluorescence assay (IFA) patterns suggest amphiphysin antibody, then the amphiphysin antibody IFA titer and amphiphysin antibody immunoblot will be performed at an additional charge.

 

If the IFA patterns suggest antiglial nuclear antibody-1 (AGNA-1), then the AGNA-1 antibody IFA titer and AGNA-1 antibody immunoblot will be performed at an additional charge.

 

If the IFA patterns suggest antineuronal nuclear antibody type 1 (ANNA-1), then the ANNA-1 IFA titer, ANNA-1 immunoblot, and ANNA-2 immunoblot will be performed at an additional charge.

 

If the client requests or the IFA pattern suggests ANNA-3 antibody, then the ANNA-3 IFA titer will be performed at an additional charge.

 

If the IFA patterns suggest collapsin response-mediator protein-5 (CRMP-5)-IgG, then the CRMP-5 antibody IFA titer and CRMP-5 antibody Western blot will be performed at an additional charge.

 

Screening tests are performed for IgG and IgM antibodies to GM1 and GD1b. If positive, the appropriate titer assay will be performed at an additional charge.

 

If the IFA pattern suggests PCA-2 antibody, then the PCA-2 antibody IFA titer and MAP1B immunoblot will be performed at an additional charge.

 

For more information see:

-Comprehensive Neuropathy Evaluation Algorithm

-Acquired Neuropathy Diagnostic Algorithm

Method Name

CNEI: Technical Interpretation

CS1CS, CS2CS, CONCS, IG5CS, LG1CS, APBCS: Cell Binding Assay (CBA)

GQ1ES, IGG_D, IGG_M, IGM_D, IGM_M, MAGES, IGDTS, IGMTS, IMDTS, IMMTS: Enzyme-Linked Immunosorbent Assay (ELISA)

NF4FS: Flow Cytometry

AMPHS, AGN1S, ANN1S, ANN3S, APBIS, CRMS, PCAB2, AGNTS, APHTS, AN1TS, AN3TS, APBTS, CRMTS, IG5TS, PC2TS: Indirect Immunofluorescence Assay (IFA)

CRMWS: Western Blot (WB)

AGNBS, AMIBS, AN1BS, AN2BS, MP1BS: Immunoblot (IB)

Specimen Type

Serum

Specimen Minimum Volume

Serum: 2 mL

Specimen Stability Information

Specimen Type Temperature Time
Serum Refrigerated (preferred) 28 days
  Frozen  28 days
  Ambient  72 hours

Reject Due To

Gross hemolysis Reject
Gross lipemia Reject
Gross icterus Reject

Day(s) Performed

Monday through Sunday

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.